Srikanth Kakumanu is a biopharmaceutical executive with deep expertise in commercialization, strategic partnerships, and innovation-driven growth in life sciences and nanomedicine. With a strong foundation in biomedical engineering and biotechnology, he specializes in bringing cutting-edge therapies to market, fostering cross-industry collaborations, and driving scientific breakthroughs in healthcare and drug development.

Holding a Ph.D. in Biomedical Engineering and Biotechnology, along with an M.Sc. in Biotechnology and an M.S. in Biomedical Engineering, Srikanth seamlessly blends technical expertise with commercial acumen. His work focuses on advancing breakthrough therapeutics, optimizing biopharmaceutical strategies, and leveraging technological innovation to improve patient outcomes.

Passionate about supporting early-stage biotech startups, Srikanth helps navigate regulatory pathways, secure funding, and develop scalable business models. As a mentor, he provides strategic insights into clinical trial execution, go-to-market strategies, and industry partnerships, enabling startups to transition from research to real-world impact.

With a multidisciplinary background spanning biopharmaceuticals, nutraceuticals, cosmeceuticals, nanomedicine, and finance, Srikanth is uniquely positioned to support founders in transforming breakthrough research into commercially viable therapies. He collaborates with startups to streamline R&D processes, optimize capital efficiency, and build sustainable growth strategies.

Currently pursuing an MBA in Finance at Cornell University’s Johnson Graduate School of Management, Srikanth is expanding his expertise in biotech investments, venture capital, and healthcare financing. His focus is on empowering biotech entrepreneurs, shaping investment strategies, and accelerating the commercialization of transformative healthcare solutions.

Based in New England,  Sri is dedicated to bridging science, business, and investment, Srikanth is committed to driving the next wave of innovation in life sciences and nanomedicine